2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide

C40H46N10O4 — CID 138688804

IUPAC2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide
SMILESCOc1cc(C)c(CC(NC(=O)C(N)CCCn2ccnc2N)C(=O)NC(Cc2cnc[nH]2)c2nc(Cc3ccc(-c4ccccc4)cc3)no2)c(C)c1
InChIInChI=1S/C40H46N10O4/c1-25-18-31(53-3)19-26(2)32(25)22-34(46-37(51)33(41)10-7-16-50-17-15-44-40(50)42)38(52)47-35(21-30-23-43-24-45-30)39-48-36(49-54-39)20-27-11-13-29(14-12-27)28-8-5-4-6-9-28/h4-6,8-9,11-15,17-19,23-24,33-35H,7,10,16,20-22,41H2,1-3H3,(H2,42,44)(H,43,45)(H,46,51)(H,47,52)
InChIKeyPAROJYUOHZNVRA-UHFFFAOYSA-N
MW730.87 g/mol
LogP4.39
Rot. Bonds17

About 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide

2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide (PubChem CID 138688804) has the molecular formula C40H46N10O4 and a molecular weight of 730.87 g/mol. Its IUPAC name is 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide.

Molecular Properties

Compound Name2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide
PubChem CID138688804
Molecular FormulaC40H46N10O4
Molecular Weight730.87 g/mol
Exact Mass730.37
IUPAC Name2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide
SMILESCOc1cc(C)c(CC(NC(=O)C(N)CCCn2ccnc2N)C(=O)NC(Cc2cnc[nH]2)c2nc(Cc3ccc(-c4ccccc4)cc3)no2)c(C)c1
InChIInChI=1S/C40H46N10O4/c1-25-18-31(53-3)19-26(2)32(25)22-34(46-37(51)33(41)10-7-16-50-17-15-44-40(50)42)38(52)47-35(21-30-23-43-24-45-30)39-48-36(49-54-39)20-27-11-13-29(14-12-27)28-8-5-4-6-9-28/h4-6,8-9,11-15,17-19,23-24,33-35H,7,10,16,20-22,41H2,1-3H3,(H2,42,44)(H,43,45)(H,46,51)(H,47,52)
InChIKeyPAROJYUOHZNVRA-UHFFFAOYSA-N
XLogP4.39
TPSA204.89 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500730.87
LogP ≤ 54.39
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Analyze 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide?
The IUPAC name of 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide (CID 138688804) is 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide.
What is the SMILES notation for 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide?
The canonical SMILES for 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide is COc1cc(C)c(CC(NC(=O)C(N)CCCn2ccnc2N)C(=O)NC(Cc2cnc[nH]2)c2nc(Cc3ccc(-c4ccccc4)cc3)no2)c(C)c1.
What is the InChIKey of 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide?
The InChIKey is PAROJYUOHZNVRA-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H46N10O4/c1-25-18-31(53-3)19-26(2)32(25)22-34(46-37(51)33(41)10-7-16-50-17-15-44-40(50)42)38(52)47-35(21-30-23-43-24-45-30)39-48-36(49-54-39)20-27-11-13-29(14-12-27)28-8-5-4-6-9-28/h4-6,8-9,11-15,17-19,23-24,33-35H,7,10,16,20-22,41H2,1-3H3,(H2,42,44)(H,43,45)(H,46,51)(H,47,52).
What are the key properties of 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide?
2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide has a molecular weight of 730.87 g/mol, XLogP of 4.39, 17 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-(2-aminoimidazol-1-yl)-N-[1-[[2-(1H-imidazol-5-yl)-1-[3-[(4-phenylphenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-(4-methoxy-2,6-dimethylphenyl)-1-oxopropan-2-yl]pentanamide is sourced from PubChem (CID 138688804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).